BriaCell Therapeutics Corp. CEO William Williams' 2022 pay slips 2% to $811K
BriaCell Therapeutics Corp. reports 2022 executive compensation
By ExecPay News
Published: January 17, 2023
BriaCell Therapeutics Corp. reported fiscal year 2022 executive compensation information on January 17, 2023.
In 2022, four executives at BriaCell Therapeutics Corp. received on average a compensation package of $438K, a 33% increase compared to previous year.
William V. Williams, Chief Executive Officer, received $811K in total, which decreased by 2% compared to 2021. 69% of Williams' compensation, or $561K, was in salary. Williams also received $150K in non-equity incentive plan and $100K in option awards.
Giuseppe Del Priore, Chief Medical Officer, received a compensation package of $416K. 52% of the compensation package, or $216K, was in option awards.
Miguel A. Lopez-Lago, Chief Scientific Officer, earned $269K in 2022, a 558% increase compared to previous year.
Gadi Levin, Chief Financial Officer, received $256K in 2022, which increases by 124% compared to 2021.
BriaCell Therapeutics Corp.'s fiscal year ends on July 31.